- R&D
- Clinical Diagnosis
- News
- Company
QuickBiology News
News Center
Here are relevant industry news and updates on our company
Joint profiling of DNA methylome and chromatin architecture at single cell solution using Methyl-HiC
Methylation status of DNA and accessibility of chromatin structure are often correlated with gene expression in eukaryotic cells. Using whole-genome bisulfite sequencing (WGBS), researchers can profile DNA methylome, while Hi-C is a comprehensive technique to capture the conformation of genomes. Read More
Deconstruction of gene regulation is critical for cell development and human diseases. Cell type-specific gene expression in eukaryotic cells is regulated not only cis-acting DNA elements (such as promoter, mRNA splicing sites), chromatin structure (accessible for transcription factors’ binding) is another level controlling gene expression. Read More
Immunotherapy is a treatment that helps the body’s own immune system fight cancer. In our body, each cell presents peptides (antigens) on the surface, some of the antigens are unique in the tumor cell surface, we call them “neoantigens”. Read More
Liquid Biopsy is the sampling and analysis of biofluids, primarily blood. It is revolutionizing oncology, an innovative solution to cancer detection. Compared to traditional solid tissue biopsies, it has “easily obtained, minimal pain/risk” etc advantages.Read More
Please explore our newly added and updated NGS service from Quick Biology in 2019 including tissue ATAC-seq, RNA/DNA Methylation Analysis, 10X Chromium Single Cell Sequencing, low-input / single cell WGS, NGS-based HLA and ABO Typing, Liquid Biopsy, Immune Repertoire Profiling, and Cancer PanelsRead More
Drug discovery is a critical element to ensure the precision medicine. Next-generation sequencing (NGS) accurately track cellular behavior at the genomic, transcriptomic level, providing an efficient technology for drug screening. Read More
There are over 6,000 known rare diseases, many or a significant portion of which affect children’s development and can be traced to changes, or mutations in a single gene. These rare genetic diseases affect an estimated 30 million Americans. Thanks to advances in genome sequencing (NGS), more and more families are receiving an accurate diagnosis for their children’s condition, NGS is having changed diagnostic workflows and provided an unprecedented, simple way of discovering novel disease-associated genes.Read More
Precision medicine is a new way of practicing medicine. Based on the individual genetic, environmental or even behavioral characteristics, doctors will provide specific strategies for target therapies and diagnosis for each patient. NGS allows rapid and accurate sequencing of many genes at once, this cutting-edge technology revolutionizes the field of genomics and medical diagnosis. Read More
Biomarker is vital for disease diagnosis and prognosis. One “biomarker” can be a protein, a metabolite, an RNA molecule or even a DNA mutation. Genomics is transforming every area of life science, next-generation sequencing (NGS) is a high-throughput genome sequencing technology, have now become mainstream in biomarker discovery. Read More
Microbe lives on or in people, plants, soil, and oceans, all over our planet. Ubiquitous and particular microbial communities are often associated with specific processes or environments. National Institute of Justice has been expanding funding of research into the forensic applications of microbiomes since 2011.Read More